-
1by Louise Carton Olivier Cottencin Maryse Lapeyre-Mestre Pierre A. Geoffroy Jonathan Favre Nicolas Simon Regis Bordet Benjamin Rolland Published in Current pharmaceutical design (01.07.2015)“...Introduction: New antipsychotics continuously arrive on the market, which thereby influences the approved and off-label prescribing (OLP) schemes. We aimed to...”
-
2by Laurent Karila Amine Benyamina Lisa Blecha Olivier Cottencin Joël Billieux Published in Current pharmaceutical design (01.11.2016)“..." Spice " is generally used to describe the diverse types of herbal blends that encompass synthetic cannabinoids on the market. The emergence of smokable...”
-
3“...fMRI-based neurofeedback (fMRI-NF) is a non-invasive technique that allows participants to achieve control of their own brain activity using the real-time...”
-
4by Ali Amad Pierre Thomas M. Mercedes Perez-Rodriguez Published in Current pharmaceutical design (01.07.2015)“...Borderline personality disorder (BPD) is a common mental disorder characterized by a pervasive pattern of emotional Borderline personality disorder (BPD) is a...”
-
5“...International audience...”
-
6
-
7by D. J. Kuss M. D. Griffiths L. Karila J. Billieux Published in Current pharmaceutical design (01.08.2014)“...In the last decade, Internet usage has grown tremendously on a global scale. The increasing popularity and frequency of Internet use has led to an increasing...”
-
8by Teresa Vanessa Fiorentino Annamaria Prioletta Pengou Zuo Franco Folli Published in Current pharmaceutical design (01.10.2013)“...Diabetes mellitus is associated to an increased risk of cardiovascular diseases. Hyperglycemia is an important factor in cardiovascular damage, working through...”
-
9“...Biofilms are microbial sessile communities characterized by cells that are attached to a substratum or interface or to each other, are embedded in a...”
-
10by Armen Yuri Gasparyan Lilit Ayvazyan Dimitri P. Mikhailidis George D. Kitas Published in Current pharmaceutical design (01.01.2011)“...Platelet activation is a link in the pathophysiology of diseases prone to thrombosis and inflammation. Numerous platelet markers, including mean platelet...”
-
11by Amir Sarrafchi Mahmoud Bahmani Hedayatollah Shirzad Mahmoud Rafieian-Kopaei Published in Current pharmaceutical design (01.01.2016)“...Parkinson's disease (PD) is a neurodegenerative disorder due to dopamine deficit in substatia nigra. PD is mainly a sporadic disease with unestablished...”
-
12by Joao Tom-Carneiro Mar Larrosa Antonio Gonzlez-Sarras Francisco A. Toms-Barbern Mara Teresa Garca-Conesa Juan Carlos Espn Published in Current pharmaceutical design (01.10.2013)“...Resveratrol (3,5,4?-trihydroxy-trans-stilbene) is a non-flavonoid polyphenol that may be present in a limited number of foodstuffs such as grapes and red wine...”
-
13by Xin-Mei Peng Guri L.V. Damu Cheng- He Zhou Published in Current pharmaceutical design (01.06.2013)“...Coumarin compounds represent an important type of naturally occurring and synthetic oxygen-containing heterocycles with typical benzopyrone framework. This...”
-
14“...Multidrug resistance (MDR) is a serious problem that hampers the success of cancer pharmacotherapy. A common mechanism is the overexpression of ATP-binding...”
-
15“...Inflammation is part of the body's response to internal and external environmental stimuli that normally eliminate the aggressor agent and restore the tissue...”
-
16“...Research into frequent, excessive, and compulsive social network activity has increased the last years, in which terms such as "social network site addiction"...”
-
17by Junichi Matsumoto Tessandra Stewart William A. Banks Jing Zhang Published in Current pharmaceutical design (01.11.2017)“...Recently, extracellular vesicles (EVs), like exosomes and microvesicles, have attracted attention as potent carriers of intercellular communication throughout...”
-
18by Nicolas Barraud Michael J. Kelso Scott A. Rice Staffan Kjelleberg Published in Current pharmaceutical design (01.01.2015)“...Studies of the biofilm life cycle can identify novel targets and strategies for improving biofilm control measures. Of particular interest are dispersal...”
-
19by Alexios S. Antonopoulos Marios Margaritis Regent Lee Keith Channon Charalambos Antoniades Published in Current pharmaceutical design (01.04.2012)“...Ample evidence exists in support of the potent anti-inflammatory properties of statins. In cell studies and animal models statins exert beneficial...”
-
20by Paolo Giorgini Paolo Di Giosia Davide Grassi Melvyn Rubenfire Robert D. Brook Claudio Ferri Published in Current pharmaceutical design (01.01.2016)“...Both high arterial blood pressure (BP) and elevated levels of fine particulate matter (PM2.5) air pollution have been associated with an increased risk for...”